Justera Health Ltd.

Justera Health Ltd., together with its subsidiaries, operates as a health and wellness management company in Canada. The company operates GoStop, a COVID-19 digital testing platform; and provides COVID-19 screening services to businesses and government organizations. It also operates Juillet Wellness Spas, a full-service wellness centre, that provides skincare, medical grade facials, physiotherapy, body massages, registered massage therapy, acupuncture, and laser hair removal services; and distributes TonyMoly skin care products. In addition, the company offers health supplements, protein products, beauty, and pet care solutions; and provides concierge medical services, including urgent concierge medical care, IV vitamin therapy, medical advisory, and preventive screenings to determine the presence or absence of disease. Justera Health Ltd. was founded in 2020 and is headquartered in Toronto, Canada.

Justera Health Ltd. trades as SCRSF on OTC. The company is classified in Healthcare / Medical - Diagnostics & Research and reports in USD.

The current profile places the business in Medical - Diagnostics & Research. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $1.42M of revenue and -$4.21M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Justera Health Ltd. can be compared against peers such as Premier Biomedical, Inc., Itonis, Inc., JRSIS Health Care Corporation, MC Endeavors, Inc., Newtopia Inc., NeutriSci International Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $600,348, beta of 1.38, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SCRSF currently shows total debt of $165,157 and beta of 1.38. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.justerahealth.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.